{"title": "Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series - PubMed", "author": "Username", "url": "https://pubmed.ncbi.nlm.nih.gov/23204169/", "hostname": "ncbi.nlm.nih.gov", "description": "The Centers for Disease Control and Prevention recommends hepatitis A virus (HAV) vaccination for all children at age 1 year and for high-risk adults. The vaccine is highly effective; however, protection duration is unknown. We report HAV antibody concentrations 17 years after childhood immunization ...", "sitename": "PubMed", "date": "2013-01-02", "cleaned_text": "Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series - PMID: 23204169 - PMCID: [PMC3611760](http://www.ncbi.nlm.nih.gov/pmc/articles/pmc3611760/) - DOI: [10.1093/infdis/jis710](https://doi.org/10.1093/infdis/jis710) Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series Abstract The Centers for Disease Control and Prevention recommends hepatitis A virus (HAV) vaccination for all children at age 1 year and for high-risk adults. The vaccine is highly effective; however, protection duration is unknown. We report HAV antibody concentrations 17 years after childhood immunization, demonstrating that protective antibody levels remain and have stabilized over the past 7 years. Figures Similar articles - [Hepatitis A vaccine immune response 22 years after vaccination.](/29663458/)J Med Virol. 2018 Aug;90(8):1418-1422. doi: 10.1002/jmv.25197. Virol. PMID: 29663458 Clinical Trial. - [Hepatitis A vaccine immunogenicity 25 Virol. 2021 PMID: 33448443 - [Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children.](/23470239/)Vaccine. 2013 Apr 19;31(17):2152-5. doi: 10.1016/j.vaccine.2013.02.048. 2013 Mar Free PMC article. - [Live Free PMC article. Review. - [Epaxal: a virosomal vaccine to prevent hepatitis A infection.](/18844588/)Expert Rev Vaccines. 2008 Oct;7(8):1141-50. doi: 10.1586/14760584.7.8.1141. Expert Rev Vaccines. 2008. PMID: 18844588 Review. Cited by - [Hepatitis A in the Eastern Mediterranean Region: PMC article. - [A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African article. A vaccination and its immunological and epidemiological long-term effects - a review 2021 Free PMC a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.](/32842988/)BMC Infect Dis. 2020 Aug 26;20(1):627. doi: 10.1186/s12879-020-05318-7. BMC 2020. PMID: 32842988 Free PMC article. - [The Impact of Vaccination Efforts on the Spatiotemporal Patterns of the Hepatitis A Outbreak in Michigan, 2016-2018.](/32618711/)Epidemiology. 2020 Sep;31(5):628-635. doi: 10.1097/EDE.0000000000001218. Epidemiology. 2020. PMID: 32618711 Free PMC article. Publication types MeSH terms Substances Grant support LinkOut - more resources Full Text Sources Medical Miscellaneous "}